-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OS4ZzAJuh2SxdJuxQ19p19UZq1zKkVVRG4UEwstl1V9wn/+SnsOjoS3VJ0WCfK53 WvOXQFRU2QT/1ePBdbfTJg== 0001181431-09-059213.txt : 20091230 0001181431-09-059213.hdr.sgml : 20091230 20091230171711 ACCESSION NUMBER: 0001181431-09-059213 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091229 FILED AS OF DATE: 20091230 DATE AS OF CHANGE: 20091230 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MEDEL ROGER MD CENTRAL INDEX KEY: 0001093125 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12111 FILM NUMBER: 091267111 MAIL ADDRESS: STREET 1: 1455 NORTH PARK DRIVE CITY: FORT LAUDERDALE STATE: FL ZIP: 33326 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDNAX, INC. CENTRAL INDEX KEY: 0000893949 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] IRS NUMBER: 650271219 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 BUSINESS PHONE: 9543840175 MAIL ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 FORMER COMPANY: FORMER CONFORMED NAME: PEDIATRIX MEDICAL GROUP INC DATE OF NAME CHANGE: 19950801 4 1 rrd261257.xml FORM 4 X0303 4 2009-12-29 0 0000893949 MEDNAX, INC. MD 0001093125 MEDEL ROGER MD 1301 CONCORD TERRACE SUNRISE FL 33323 1 1 0 0 Chief Executive Officer Common Stock 2009-12-29 4 M 0 30000 12.90 A 273825 D Common Stock 2009-12-29 4 S 0 30000 60.9843 D 243825 D Common Stock 2009-12-30 4 M 0 16427 12.90 A 260252 D Common Stock 2009-12-30 4 S 0 16427 60.6805 D 243825 D Common Stock 480 I By Child Stock Options 12.90 2009-12-29 4 M 0 30000 0 D 2003-04-02 2013-04-02 Common Stock 30000 112475 D Stock Options 12.90 2009-12-29 4 M 0 16427 0 D 2003-04-02 2013-04-02 Common Stock 16427 96048 D These sales were made pursuant to the Reporting Person's Rule 10b5-1 trading plan. Sales of shares were executed in fifty-five (55) separate transactions with prices ranging from $60.67 to $61.35 for a weighted average of $60.9843. Sales of shares were executed in fifty-one (51) separate transactions with prices ranging from $60.40 to $61.01 for a weighted average of $60.6805. /s/ Thomas W. Hawkins, Attorney-In-Fact 2009-12-30 -----END PRIVACY-ENHANCED MESSAGE-----